Literature DB >> 15221788

Molecular screening of SHH, ZIC2, SIX3, and TGIF genes in patients with features of holoprosencephaly spectrum: Mutation review and genotype-phenotype correlations.

Christèle Dubourg1, Leïla Lazaro, Laurent Pasquier, Claude Bendavid, Martine Blayau, Franck Le Duff, Marie-Renée Durou, Sylvie Odent, Véronique David.   

Abstract

Holoprosencephaly (HPE; 1 out of 16,000 live births; 1 out of 250 conceptuses) is a complex brain malformation resulting from incomplete cleavage of the prosencephalon, affecting both the forebrain and the face. Clinical expressivity is variable, ranging from a single cerebral ventricle and cyclopia to clinically unaffected carriers in familial dominant autosomic HPE. The disease is genetically heterogeneous, but additional environmental agents also contribute to the etiology of HPE. In our cohort of 200 patients, 34 heterozygous mutations were identified, 24 of them being novel ones: 13 out of 17 in the Sonic hedgehog gene (SHH); 4 out of 7 in ZIC2; and 7 out of 8 in SIX3. The two mutations identified in TGIF have already been reported. Novel phenotypes associated with a mutation have been described, such as abnormalities of the pituitary gland and corpus callosum, colobomatous microphthalmia, choanal aperture stenosis, and isolated cleft lip. This study confirms the great genetic heterogeneity of the disease, the important phenotypic variability in HPE families, and the difficulty to establish genotype-phenotype correlations. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15221788     DOI: 10.1002/humu.20056

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  52 in total

1.  The unfolding clinical spectrum of holoprosencephaly due to mutations in SHH, ZIC2, SIX3 and TGIF genes.

Authors:  Aimée D C Paulussen; Constance T Schrander-Stumpel; Demis C J Tserpelis; Matteus K M Spee; Alexander P A Stegmann; Grazia M Mancini; Alice S Brooks; Margriet Collée; Anneke Maat-Kievit; Marleen E H Simon; Yolande van Bever; Irene Stolte-Dijkstra; Wilhelmina S Kerstjens-Frederikse; Johanna C Herkert; Anthonie J van Essen; Klaske D Lichtenbelt; Arie van Haeringen; Mei L Kwee; Augusta M A Lachmeijer; Gita M B Tan-Sindhunata; Merel C van Maarle; Yvonne H J M Arens; Eric E J G L Smeets; Christine E de Die-Smulders; John J M Engelen; Hubertus J Smeets; Jos Herbergs
Journal:  Eur J Hum Genet       Date:  2010-06-09       Impact factor: 4.246

2.  Gorlin syndrome: the PTCH gene links ocular developmental defects and tumour formation.

Authors:  N K Ragge; A Salt; J R O Collin; A Michalski; P A Farndon
Journal:  Br J Ophthalmol       Date:  2005-08       Impact factor: 4.638

Review 3.  Genetic defects of human brain development.

Authors:  Jenny Carmichael; Christopher Woods
Journal:  Curr Neurol Neurosci Rep       Date:  2006-09       Impact factor: 5.081

4.  Utilizing prospective sequence analysis of SHH, ZIC2, SIX3 and TGIF in holoprosencephaly probands to describe the parameters limiting the observed frequency of mutant gene×gene interactions.

Authors:  Erich Roessler; Jorge I Vélez; Nan Zhou; Maximilian Muenke
Journal:  Mol Genet Metab       Date:  2012-01-12       Impact factor: 4.797

5.  Molecular evaluation of foetuses with holoprosencephaly shows high incidence of microdeletions in the HPE genes.

Authors:  Claude Bendavid; Christèle Dubourg; Isabelle Gicquel; Laurent Pasquier; Pascale Saugier-Veber; Marie-Renée Durou; Sylvie Jaillard; Thierry Frébourg; Bassem R Haddad; Catherine Henry; Sylvie Odent; Véronique David
Journal:  Hum Genet       Date:  2005-12-02       Impact factor: 4.132

Review 6.  From human genetics and genomics to pharmacogenetics and pharmacogenomics: past lessons, future directions.

Authors:  Daniel W Nebert; Ge Zhang; Elliot S Vesell
Journal:  Drug Metab Rev       Date:  2008       Impact factor: 4.518

7.  Mutations in ZIC2 in human holoprosencephaly: description of a novel ZIC2 specific phenotype and comprehensive analysis of 157 individuals.

Authors:  Benjamin D Solomon; Felicitas Lacbawan; Sandra Mercier; Nancy J Clegg; Mauricio R Delgado; Kenneth Rosenbaum; Christèle Dubourg; Veronique David; Ann Haskins Olney; Lars-Erik Wehner; Ute Hehr; Sherri Bale; Aimee Paulussen; Hubert J Smeets; Emily Hardisty; Anna Tylki-Szymanska; Ewa Pronicka; Michelle Clemens; Elizabeth McPherson; Raoul C M Hennekam; Jin Hahn; Elaine Stashinko; Eric Levey; Dagmar Wieczorek; Elizabeth Roeder; Chayim Can Schell-Apacik; Carol W Booth; Ronald L Thomas; Sue Kenwrick; Derek A T Cummings; Sophia M Bous; Amelia Keaton; Joan Z Balog; Donald Hadley; Nan Zhou; Robert Long; Jorge I Vélez; Daniel E Pineda-Alvarez; Sylvie Odent; Erich Roessler; Maximilian Muenke
Journal:  J Med Genet       Date:  2009-12-02       Impact factor: 6.318

8.  The full spectrum of holoprosencephaly-associated mutations within the ZIC2 gene in humans predicts loss-of-function as the predominant disease mechanism.

Authors:  Erich Roessler; Felicitas Lacbawan; Christèle Dubourg; Aimee Paulussen; Jos Herbergs; Ute Hehr; Claude Bendavid; Nan Zhou; Maia Ouspenskaia; Sherri Bale; Sylvie Odent; Vèronique David; Maximilian Muenke
Journal:  Hum Mutat       Date:  2009-04       Impact factor: 4.878

9.  Mutational analyses of UPIIIA, SHH, EFNB2 and HNF1beta in persistent cloaca and associated kidney malformations.

Authors:  Dagan Jenkins; Maria Bitner-Glindzicz; Louise Thomasson; Sue Malcolm; Stephanie A Warne; Sally A Feather; Sarah E Flanagan; Sian Ellard; Coralie Bingham; Lane Santos; Mark Henkemeyer; Andrew Zinn; Linda A Baker; Duncan T Wilcox; Adrian S Woolf
Journal:  J Pediatr Urol       Date:  2007-02       Impact factor: 1.830

10.  The mutational spectrum of holoprosencephaly-associated changes within the SHH gene in humans predicts loss-of-function through either key structural alterations of the ligand or its altered synthesis.

Authors:  Erich Roessler; Kenia B El-Jaick; Christèle Dubourg; Jorge I Vélez; Benjamin D Solomon; Daniel E Pineda-Alvarez; Felicitas Lacbawan; Nan Zhou; Maia Ouspenskaia; Aimée Paulussen; Hubert J Smeets; Ute Hehr; Claude Bendavid; Sherri Bale; Sylvie Odent; Véronique David; Maximilian Muenke
Journal:  Hum Mutat       Date:  2009-10       Impact factor: 4.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.